The first Physician Operating Device (POD) being developed is the platform technology BarrelEye ® to deliver a proprietary therapy using a form of RF energy to cure or reduce valvular insufficiency by at least two grade levels in the mitral and tricuspid valvular apparatus.

 

The second is Mitratight, a surgical version of that technology.